Semler Scientific Stock Prediction and Forecast [SMLR]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 23 Sept 2025, 04:19 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for Semler Scientific Stock Prediction and Forecast [SMLR]](https://i.ytimg.com/vi/zI7VteMKknM/hqdefault.jpg)
AI-generated source summary
The analysis of Semler Scientific (SMLR) indicates it is positioned at the upper part of a declining trend, suggesting a favorable selling opportunity for short-term traders, with an anticipated reaction back toward the lower part of the trend. A breakout above $32.91 indicates a slower rate of decline and potential trend reversal. The three-month trend indicates a potential decline of approximately 32.9% , with possible returns ranging from -43.68% to -31.13%. Long-term analysis (12 months) suggests a projected change of -15.38%, with potential range from -72.64% and 73.34%. The last trading day price had a 9.87% increase, closing at $32.06. Recent news notes potential share holder litigation. Positive signals exist, but a sell signal arises due to moving averages. Support is found at $29.30 and $31.33, but breaking those values trigger sell signals.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.